Ichiro Kikushige has been appointed chief executive officer of Teva Seiyaku, Japan, effective on May 15, 2013. Mr. Kikushige will replace Makoto Shimada, who is retiring after serving 40 years in Japan’s pharma industry. Mr. Shimada will stay with the company until June 30, 2013 to facilitate a smooth transition.   “As an effective leader with more than 30 years of experience in the pharmaceutical industry, Mr. Kikushige is well-qualified to assume this important role within Teva in Japan,” said...